Supplementary Figure 2 from A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Authors:
- Matthew T. CampbellMCMatthew T. Campbell
- Amishi Y. ShahASAmishi Y. Shah
- Pavlos MsaouelPavlos Msaouel
- Nizar M. TannirNTNizar M. Tannir
- Arlene O. Siefker-RadtkeASArlene O. Siefker-Radtke
- Ashish M. KamatAshish M. Kamat
- Neema NavaiNNNeema Navai
- Colin P.N. DinneyCDColin P.N. Dinney
- Priya RaoPRPriya Rao
- Charles C. GuoCharles C. Guo
- Rahul A. ShethRSRahul A. Sheth
- Aradhana M. VenkatesanAVAradhana M. Venkatesan
Open Access
- 3 April 2025
- other
- Published by American Association for Cancer Research (AACR)